International Patent: CRISPR/CAS-BASED IN-SITU NUCLEIC ACID DETECTION METHOD FOR INTRACELLULAR MYCOBACTERIUM TUBERCULOSIS AND USE THEREOF

GENEVA, July 9 -- SHENZHEN THIRD PEOPLE'S HOSPITAL (SHENZHEN INSTITUTE OF HEPATOLOGY) filed a patent application (CN2025/092831) for “CRISPR/CAS-BASED IN-SITU NUCLEIC ACID DETECTION METHOD FOR INTRACELLULAR MYCOBACTERIUM TUBERCULOSIS AND USE THEREOF”. With publication no. WO/2026/143924, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12Q 1/689

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....